• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 029 Publication Date: 08/20/2012 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 11-242: ASTM F1839-08e2, Standard Specification for Rigid Polyurethane Foam for Use as a Standard Material for Testing Orthopaedic Devices and Instruments. (Orthopaedics)

Date of Standard: 2008. 
Address of Standards Organization:
  ASTM International (ASTM)
  100 Barr Harbor Drive
  West Conshohocken, PA 19428-2959
 
CDRH Office and Division Associated with Recognized Standards:
OFFICE OF DEVICE EVALUATION (ODE)
Devices Affected:
Synthetic bone block
Processes Affected:
510(k), IDE, HDE, PMA, PDP, Design Controls
Type of Standard:
 Vertical, National, Test Methods
Extent of Recognition:
Complete standard

This specification lists the requirements for various physical and mechanical properties of various grades of polyurethane "bone substitute" blocks. When used to assess the performance of fixation devices in bone, care should be taken to select the worst-case grade for the intended use (e.g. insertion or pullout) and anatomic location.
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§888.3030 Fastener, Fixation, Biodegradable, Soft Tissue Class 2 MAI
 
Regulation
Number
Device Name Device
Class
Product
Code
§888.3040 Fastener, Fixation, Nondegradable, Soft Tissue Class 2 MBI
§888.3040 Screw, Fixation, Bone Class 2 HWC
§888.3040 Screw, Fixation, Bone, Non-Spinal, Metallic Class 2 NDJ
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contact:
  Michael Kasser
  FDA/CDRH/ODE
  10903 New Hampshire Avenue Building 66, Room 1576
  Silver Spring MD 20993
  301/796-6946
  Email: michael.kasser@fda.hhs.gov
-
-